SG11202005652YA - Once-daily formulation of hidrosmin - Google Patents
Once-daily formulation of hidrosminInfo
- Publication number
- SG11202005652YA SG11202005652YA SG11202005652YA SG11202005652YA SG11202005652YA SG 11202005652Y A SG11202005652Y A SG 11202005652YA SG 11202005652Y A SG11202005652Y A SG 11202005652YA SG 11202005652Y A SG11202005652Y A SG 11202005652YA SG 11202005652Y A SG11202005652Y A SG 11202005652YA
- Authority
- SG
- Singapore
- Prior art keywords
- hidrosmin
- once
- daily formulation
- daily
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17382877 | 2017-12-21 | ||
| PCT/EP2018/086053 WO2019122051A1 (en) | 2017-12-21 | 2018-12-20 | Once-daily formulation of hidrosmin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202005652YA true SG11202005652YA (en) | 2020-07-29 |
Family
ID=60923332
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202005652YA SG11202005652YA (en) | 2017-12-21 | 2018-12-20 | Once-daily formulation of hidrosmin |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP3727345A1 (en) |
| AR (1) | AR113993A1 (en) |
| BR (1) | BR112020012437A2 (en) |
| CL (1) | CL2020001697A1 (en) |
| CO (1) | CO2020008721A2 (en) |
| CR (1) | CR20200320A (en) |
| EA (1) | EA202091535A1 (en) |
| EC (1) | ECSP20041796A (en) |
| MX (1) | MX2020006505A (en) |
| NI (1) | NI202000049A (en) |
| PE (1) | PE20210458A1 (en) |
| PH (1) | PH12020550926A1 (en) |
| SG (1) | SG11202005652YA (en) |
| UY (1) | UY38026A (en) |
| WO (1) | WO2019122051A1 (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5894720B2 (en) | 2010-05-11 | 2016-03-30 | シマ ラブス インク． | Alcohol resistant formulation |
| CN108366969A (en) | 2015-10-09 | 2018-08-03 | 拜尔健康护理有限责任公司 | The Modified Release Formulation of naproxen sodium |
-
2018
- 2018-12-19 AR ARP180103740A patent/AR113993A1/en unknown
- 2018-12-20 BR BR112020012437-0A patent/BR112020012437A2/en unknown
- 2018-12-20 SG SG11202005652YA patent/SG11202005652YA/en unknown
- 2018-12-20 WO PCT/EP2018/086053 patent/WO2019122051A1/en active Search and Examination
- 2018-12-20 EA EA202091535A patent/EA202091535A1/en unknown
- 2018-12-20 UY UY0001038026A patent/UY38026A/en not_active Application Discontinuation
- 2018-12-20 MX MX2020006505A patent/MX2020006505A/en unknown
- 2018-12-20 PE PE2020000781A patent/PE20210458A1/en unknown
- 2018-12-20 EP EP18826649.8A patent/EP3727345A1/en active Pending
- 2018-12-20 CR CR20200320A patent/CR20200320A/en unknown
-
2020
- 2020-06-17 PH PH12020550926A patent/PH12020550926A1/en unknown
- 2020-06-19 CL CL2020001697A patent/CL2020001697A1/en unknown
- 2020-06-19 NI NI202000049A patent/NI202000049A/en unknown
- 2020-07-15 CO CONC2020/0008721A patent/CO2020008721A2/en unknown
- 2020-07-20 EC ECSENADI202041796A patent/ECSP20041796A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UY38026A (en) | 2019-07-31 |
| AR113993A1 (en) | 2020-07-08 |
| EP3727345A1 (en) | 2020-10-28 |
| NI202000049A (en) | 2020-11-24 |
| WO2019122051A1 (en) | 2019-06-27 |
| CL2020001697A1 (en) | 2020-11-27 |
| BR112020012437A2 (en) | 2020-11-24 |
| CO2020008721A2 (en) | 2020-12-10 |
| PE20210458A1 (en) | 2021-03-08 |
| MX2020006505A (en) | 2020-09-17 |
| EA202091535A1 (en) | 2020-09-11 |
| PH12020550926A1 (en) | 2021-05-31 |
| CR20200320A (en) | 2020-12-14 |
| ECSP20041796A (en) | 2020-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| IL274139A (en) | Aerosolisable formulation | |
| IL274627A (en) | Solid state form of valbenazine | |
| GB201707930D0 (en) | Formulation component | |
| GB201701239D0 (en) | Novel formulation | |
| IL274719A (en) | Formulation | |
| IL272857A (en) | Formulations of copanlisib | |
| PT3320901T (en) | Application of dimethylamino micheliolide | |
| GB201713724D0 (en) | Formulation | |
| EP3721889A4 (en) | Use of butyribacter intestini | |
| GB201706969D0 (en) | Formulation | |
| ZA201906238B (en) | New therapeutical use of h3-ligands | |
| PL3582617T3 (en) | Stable formulation of pesticidal pyridazinpyrazolamides | |
| SG11202105136WA (en) | Application of chidamide | |
| PT3678644T (en) | Formulations of copanlisib | |
| GB201719464D0 (en) | Formulation | |
| SG11202005652YA (en) | Once-daily formulation of hidrosmin | |
| GB2568045B (en) | Formulation | |
| GB201721386D0 (en) | Chrondogy of time-wave | |
| GB201720808D0 (en) | Formulation | |
| GB201719377D0 (en) | Novel formulation | |
| GB201719411D0 (en) | Novel formulation | |
| GB201719410D0 (en) | Novel formulation | |
| GB201717131D0 (en) | Novel formulation | |
| GB201700257D0 (en) | New formulation |